Fewer people were served across UnitedHealth's insurance and care businesses in the six months ended June 30. That did not stop the company from lifting operating income 55.2% to $8.0 billion and net income 61.0% to $5.5 billion.
The key contrast is in the sales line: revenue reached $112.0 billion, up just 0.4% from the comparable six months last year. UnitedHealth produced a much larger earnings gain from pricing, fewer medical costs, reserve development, and cost management than from adding volume.
That mix matters because it makes the margin improvement look more operational than top-line. Operating margin rose to 7.1% from 4.6%, while operating cash flow climbed 57.9% to $20.0 billion. Accounts receivable fell 10.6% to $21.6 billion, giving cash conversion a cleaner-looking period as well.
UnitedHealth described the revenue trade-off plainly:
"The increases in revenues were primarily driven by pricing trends at UnitedHealthcare, partially offset by decreased people served through Medicare Advantage, commercial risk-based offerings and Medicaid and a decrease in patients served under value-based arrangements at Optum Health."
UnitedHealth Group, 10-Q, Aug. 10, 2026
In other words, price did the growing while membership and patient volume moved the other way. The six-month result is not a volume-led expansion, at least on the disclosures provided.
The medical-cost line supplied the larger earnings lever, while the filing also noted an offsetting pressure:
"Medical costs decreased primarily due to fewer people served across UnitedHealthcare and Optum Health and favorable prior period reserve development, partially offset by elevated medical cost trend which remains above historical levels and continues to be affected by higher provider reimbursement under the No Surprises Act and increased service and coding intensity in commercial."
UnitedHealth Group, 10-Q, Aug. 10, 2026
The filing links fewer people served to lower medical costs, and favorable reserve development helped too. But UnitedHealth says the underlying medical-cost trend remains above historical levels, with reimbursement rules and service intensity adding pressure. The accounting benefit and the operating pressure are sharing the same paragraph, a crowded neighborhood.
Management also attributed higher operating earnings to affordability and medical-cost management initiatives, partially offset by investments supporting future growth. Capex fell to $1.6 billion from $1.8 billion, while stock compensation rose to $624 million from $572 million. Diluted shares still edged down 0.4%, so the period had both a modest share-count tailwind and a higher compensation expense.
The latest six-month margin is above UnitedHealth's 2025 full-year operating margin of 4.2%, but the annual history shows why one period does not settle the question. Revenue grew 11.8% last year, even as operating margin contracted, leaving the company with two different operating stories: sales can grow faster than they did here, and profitability can recover without much sales growth.
Optum Health adds a specific constraint to that tension. UnitedHealth says its fully accountable value-based care businesses have been affected by Medicare funding reductions and continued medical-cost pressure, which may affect future pricing in markets where it participates. That puts the current cost environment alongside a possible effect on future pricing in the markets where it participates, not a generic industry risk.
UnitedHealth's next quarterly report can be read against one concrete disclosure: whether the number of people served continues to fall or begins to stabilize. For now, the six-month trade-off is simple enough: earnings and operating cash flow increased while fewer people were served, with medical costs still sending the bill.
Source: UnitedHealth Group's 10-Q filed Aug. 10, 2026, for the six months ended June 30, 2026.